Although there is clear recognition of the need to intensify treatment for many people with T2D, timely and appropriate intensification of insulin therapy does not occur3, possibly due to fear of side-effects, individual choice or low health literacy. The gene discussed is INS; the disease is type 2 diabetes mellitus.